More recently, a study comparing adiponectin levels of 17 CF patients with the CFTR I1234V mutation to those of 18 healthy controls found that sputum adiponectin levels could be used to asses inflammatory status among CF patients in a minimally invasive manner [31]. This evidence concerns the gene ADIPOQ and cystic fibrosis.